How to Document Cardiology Patient Visits and Heart Failure Management Plans

A practical documentation guide for cardiologists, NPs, and PAs. Covers initial consultations, follow-up visit structure, heart failure staging and management documentation, EKG and echo interpretation notes, cardiac procedure records, device management, and quality reporting requirements.

Cardiology documentation carries a clinical and medicolegal weight that is hard to overstate. A cardiologist's note may be reviewed by an insurance medical director deciding whether to approve a transcatheter valve replacement, a hospitalist managing an overnight decompensation, a plaintiff's attorney in a malpractice case, or a cardiovascular registry pulling quality metrics. The note has to hold up under all of those uses at once.

This guide is written for cardiologists, advanced practice providers (APPs) in cardiology, and NPs and PAs managing cardiology patients in outpatient or inpatient settings. It covers the documentation structure for initial consultations, follow-up visits, heart failure (HF) management, cardiac procedure records, and device management, with specific attention to payer requirements and quality reporting.

Why Cardiology Documentation Differs from General Medicine

Cardiology notes require a level of objective specificity that most other outpatient specialties do not. An internist can document "hypertension, well-controlled" and that is often sufficient. A cardiologist documenting a patient with hypertensive heart disease needs to record the blood pressure trend, left ventricular wall thickness, diastolic function grade, and medication titration rationale in the same note, because each of those elements can become clinically critical within the same visit.

The other challenge is the layered nature of cardiovascular care. A patient presenting to cardiology may have coronary artery disease (CAD), atrial fibrillation (AF), heart failure with preserved ejection fraction (HFpEF), diabetes, and chronic kidney disease simultaneously. The documentation must account for each condition's status without collapsing them into a generic problem list update.

Finally, cardiology has an active quality reporting infrastructure. The American College of Cardiology (ACC) and American Heart Association (AHA) maintain performance measures and registry participation requirements that depend on specific data fields being captured at each visit. Notes that are clinically adequate but documentation-incomplete will fail to feed those registries accurately.

Initial Consultation Documentation

The cardiology initial consultation note is the most important note in a patient's cardiovascular record. It establishes the diagnostic framework that all subsequent notes build on. A weak initial note creates ambiguity that compounds over years of care.

History of Present Illness

The history of present illness (HPI) in a cardiology consultation should answer: Why is this patient here now, and what is the cardiovascular question being asked?

That second part matters. Cardiology consults often come from other providers with a specific question (e.g., "Is this patient's exertional dyspnea of cardiac origin?" or "Evaluate for anticoagulation in new-onset AF"). When a consult question exists, document it explicitly at the top of the HPI. It shapes the entire diagnostic approach and demonstrates that the consultation addressed what was asked.

For new patients presenting with chest pain, the HPI should capture:

Character (pressure, burning, sharp, tearing), location, and radiation
Duration and frequency of episodes
Provocating and relieving factors, including rest and nitroglycerin response
Associated symptoms: dyspnea, diaphoresis, palpitations, presyncope, syncope
Chronology: first episode, worst episode, change in pattern

For dyspnea presentations, document New York Heart Association (NYHA) functional class at baseline and at current presentation. "Dyspnea with moderate exertion" is incomplete. "Patient reports dyspnea climbing one flight of stairs, which represents a decline from baseline six months ago when dyspnea occurred only with two or more flights" tells a story that supports both medical necessity and clinical decision-making.

Cardiac History and Risk Factor Documentation

Cardiovascular documentation requires a dedicated cardiac history section that stands separate from the general past medical history. This section should include:

Prior cardiac diagnoses with dates of diagnosis and key workup findings (e.g., "myocardial infarction (MI), 2021, anterior wall, treated with percutaneous coronary intervention (PCI) at left anterior descending (LAD) territory, drug-eluting stent placed")
Prior cardiac procedures and surgeries with dates and institutions
Prior imaging: most recent echocardiogram (echo) with ejection fraction, most recent stress test with result and modality, prior cardiac catheterization findings
Cardiac medications with doses and duration

Cardiovascular risk factors should be documented with specificity. Not just "diabetes" but "type 2 diabetes, diagnosed 2017, current HbA1c 8.1%, on metformin and empagliflozin." Not just "smoking history" but "former smoker, quit 2019, 25 pack-years." This specificity matters for risk stratification tools like the ACC/AHA Pooled Cohort Equations for atherosclerotic cardiovascular disease (ASCVD) risk and for quality reporting fields.

Physical Examination in Cardiology

The cardiac physical exam has specific components that need to be documented completely, particularly for HF and valvular disease patients:

Vital signs with blood pressure in both arms if aortic disease is a consideration
Jugular venous pressure (JVP) or jugular venous distension (JVD), estimated in cm above the sternal angle
Heart sounds: S1 and S2 quality, presence of S3 gallop (a significant HF marker), S4 gallop, murmurs with grading (e.g., "grade 3/6 holosystolic murmur, best heard at apex with radiation to axilla"), and location of point of maximal impulse (PMI)
Respiratory findings: rales, Cheyne-Stokes breathing, use of accessory muscles
Peripheral perfusion: presence of pitting edema with grading (1+ through 4+) and extent (ankle, pretibial, knee), capillary refill, skin temperature and color
Hepatomegaly or hepatojugular reflux when relevant to volume assessment

For a patient with known HF, these exam components are not optional. They are the clinical data points that define volume status and guide immediate management.

Documenting Objective Diagnostic Findings

EKG Interpretation

Electrocardiogram (EKG) documentation should reflect the cardiologist's actual interpretation, not just a reference to the tracing. Documenting "EKG reviewed" with no interpretation is insufficient for clinical, billing, and medicolegal purposes.

A complete EKG interpretation note includes:

Rate and rhythm (e.g., "sinus rhythm at 72 bpm")
PR interval, QRS duration, and QTc interval with measurement
Axis
Evidence of left ventricular hypertrophy (LVH), right ventricular hypertrophy (RVH), or chamber enlargement
ST and T-wave changes with specific leads (e.g., "ST depression 1 mm in leads V4-V6, TWI in I and aVL")
Bundle branch blocks or conduction abnormalities
Comparison to prior EKG if available, noting any new or changed findings

Fictional example: Dr. Amara Osei, a cardiologist in a cardiology group practice, sees Elena V., a 67-year-old woman presenting with progressive exertional dyspnea. Dr. Osei's EKG note documents: "Sinus rhythm, rate 82. PR interval 184 ms. QRS duration 96 ms. QTc 438 ms. Left axis deviation. Voltage criteria for LVH met (Sokolow-Lyon index 42 mm). Diffuse lateral ST flattening. No acute ST elevation or depression. Comparison to EKG from 14 months prior: new lateral ST changes." This interpretation directly informs her recommendation for echocardiography and her differential diagnosis.

Echocardiogram Findings Documentation

When the cardiologist is interpreting or reviewing an echocardiogram, the note should include key quantitative findings, not just qualitative conclusions. "Echo shows normal LV function" is insufficient for a cardiology record.

Document:

Left ventricular ejection fraction (LVEF) with method (visual estimate, biplane Simpson's method, 3D volumetric) and numerical range if a single figure is not obtained
LV end-diastolic dimension (LVEDD) and wall thickness measurements
Diastolic dysfunction grade (I through IV per ASE guidelines), with E/A ratio, tissue Doppler e' velocity, E/e' ratio, and left atrial volume index (LAVI) if available
Valve findings: each valve assessed individually with regurgitation severity graded by current guidelines (mild, moderate, severe; with effective regurgitant orifice area (EROA) for significant lesions) and stenosis severity (peak gradient, mean gradient, valve area for significant stenosis)
Wall motion abnormalities with territory mapped to coronary distribution (e.g., "akinesis of mid-apical inferoseptal segments, consistent with LAD territory")
Pericardial effusion if present, with estimated size and hemodynamic effect assessment
Right heart: RV size and function, estimated right ventricular systolic pressure (RVSP) from TR jet

Cardiac Catheterization Documentation

Documentation of coronary anatomy from cardiac catheterization should specify:

Dominant circulation (right, left, or co-dominant)
Each coronary vessel with percent stenosis in specific segments (e.g., "LAD: 70% stenosis at proximal-to-mid LAD junction; LCX: non-obstructive disease, 30% stenosis at OM1 origin; RCA: dominant, 80% proximal RCA stenosis")
Hemodynamic data when obtained (right heart cath pressures, cardiac output, pulmonary capillary wedge pressure (PCWP))
Findings that support or exclude specific diagnoses (e.g., fractional flow reserve (FFR) for intermediate lesions, intravascular ultrasound (IVUS) findings)

The downstream clinical decision, such as whether to proceed with revascularization, should be documented with explicit reference to the anatomy: "Given significant LAD and RCA disease, case was discussed with cardiothoracic surgery for consideration of coronary artery bypass grafting (CABG)."

Heart Failure Staging and Management Documentation

Heart failure documentation requires more than a problem list entry. The note needs to capture HF classification, current volume status, medication optimization status, and patient trajectory.

Classifying Heart Failure

Every HF patient note should document:

HF phenotype: HF with reduced ejection fraction (HFrEF), HF with mildly reduced ejection fraction (HFmrEF), or HF with preserved ejection fraction (HFpEF), with the most recent LVEF that supports this classification
ACC/AHA HF Stage: Stage A (at risk, no structural disease), B (structural disease, no symptoms), C (structural disease with current or prior symptoms), or D (refractory HF requiring advanced therapies)
NYHA Functional Class: I through IV, assessed at this visit
HF etiology when established (ischemic, non-ischemic dilated, hypertensive, valvular, familial/genetic, peripartum, toxic, etc.)

This classification changes. Document it at every HF visit. A patient who was NYHA Class II at the last visit and is now NYHA Class III has had a meaningful clinical event, even if no acute decompensation occurred.

Documenting Guideline-Directed Medical Therapy

For HFrEF, the guideline-directed medical therapy (GDMT) documentation framework asks: Is the patient on the four pillars, and if not, why?

The four classes of GDMT for HFrEF are:

ACE inhibitor, ARB, or ARNI (sacubitril-valsartan)
Beta-blocker (carvedilol, metoprolol succinate, or bisoprolol)
Mineralocorticoid receptor antagonist (MRA) (spironolactone or eplerenone)
SGLT2 inhibitor (dapagliflozin or empagliflozin)

For each agent, document: drug name, dose, date last titrated, current dose relative to target dose, and any barriers to uptitration (e.g., "Carvedilol 12.5 mg BID, uptitration to 25 mg BID deferred due to systolic BP 92 mmHg at today's visit").

If any of the four classes is absent from the regimen, document the reason explicitly. "ACE inhibitor not prescribed" without explanation is an audit flag and a quality reporting failure. "ACE inhibitor and ARB both contraindicated due to eGFR of 28 and serum potassium of 5.6 mEq/L; ARNI also deferred due to concurrent ACE inhibitor washout period not yet completed" is a complete record.

Fictional example: Dr. Osei is managing Marcus R., a 54-year-old man with HFrEF, LVEF 32%, NYHA Class II. At today's visit, LVEF has remained stable, but his systolic blood pressure is 88 mmHg. Dr. Osei's note documents: "GDMT review: Sacubitril-valsartan 97/103 mg BID, continued; metoprolol succinate 50 mg daily, did not uptitrate given SBP 88 at today's visit; spironolactone 25 mg daily, continued; empagliflozin 10 mg daily, continued. Target doses deferred for beta-blocker pending BP stability. Will recheck in 4 weeks."

Volume Status Assessment

Every HF visit note should include a documented volume status assessment. This is not a single-word entry. It is a synthesis of exam and history:

Changes in weight since last visit (document patient's home scale weight alongside clinic weight)
Lower extremity edema: grade and distribution
JVP estimation
Presence or absence of orthopnea, paroxysmal nocturnal dyspnea, and the number of pillows used for sleeping
Lung exam findings
Assessment: euvolemic, mild congestion, moderate congestion, or significant congestion

The plan should directly follow the assessment. If the patient is mildly congested, document what diuretic adjustment is being made and what follow-up is planned to confirm response.

Loop Diuretic Titration Records

For HF patients on loop diuretics, document:

Current dose and frequency of furosemide, torsemide, or bumetanide
Recent dose changes with dates and rationale
Renal function and electrolytes at the time of any dose change (eGFR, BUN, creatinine, potassium, sodium)
Patient education provided about self-monitoring: weight-based action plan, when to call the office, when to go to the emergency department

A loop diuretic change without documented labs and patient education creates liability. If the patient develops acute kidney injury or a potassium of 3.0 mEq/L two weeks after a dose escalation, the question will be: what was the baseline, and was the patient counseled?

Cardiac Procedure Documentation

Procedure Notes vs. Post-Procedure Follow-Up Notes

The procedure note (written at the time of the procedure) and the post-procedure follow-up note serve different functions.

The procedure note documents: indication, consent obtained, anesthesia type, access site, equipment used (including catheter sizes, fluoroscopy time, contrast volume), intraoperative findings, any complications or unexpected events, and post-procedure instructions. For catheterization, this includes hemostasis method and time to ambulation.

The post-procedure follow-up note (at the first post-procedure visit) should reference the procedure note findings, document symptom resolution or persistence, assess the access site, review labs drawn post-procedure, and confirm the updated medication plan. "Patient doing well after cath" is not a post-procedure note.

Cardioversion Documentation

For direct current cardioversion (DCCV) or pharmacologic cardioversion for atrial fibrillation:

Document the anticoagulation strategy pre-cardioversion and how it was verified (minimum 3 weeks of therapeutic anticoagulation, or transesophageal echocardiography excluding thrombus)
Energy settings for DCCV and number of attempts
Pre- and post-cardioversion rhythm
CHA2DS2-VASc score with individual components documented, and anticoagulation plan post-cardioversion
The duration-of-AF estimate that informed the decision to cardiovert

Stress Test and Nuclear Imaging Documentation

Interpretation notes for exercise stress tests, pharmacologic stress tests, and nuclear perfusion studies should be provider-authored, not copy-pasted from the testing summary:

The functional capacity achieved (in METs for exercise tests)
Hemodynamic response: peak heart rate achieved vs. target heart rate, blood pressure response
Symptoms during testing (chest pain, dyspnea, arrhythmia)
EKG changes during exercise with leads and magnitude
For nuclear studies: distribution and severity of any perfusion abnormalities, estimated ischemic burden

Device Management Documentation

Pacemakers and ICDs

Documentation for patients with permanent pacemakers or implantable cardioverter-defibrillators (ICDs) at device clinic visits should include:

Device type, manufacturer, and implant date
Current programmed settings: lower rate limit, upper rate limit (for dual-chamber or rate-responsive devices), pacing mode (e.g., DDD, VVI)
Percent pacing in each chamber (atrial and ventricular) since last interrogation
Battery status and estimated remaining longevity
Lead integrity: sensing thresholds, pacing thresholds, and impedances for each lead, compared to prior values
Arrhythmia log review: any stored episodes, therapies delivered (ATP or shock), and the clinical context (were these appropriate or inappropriate therapies?)
Any patient-reported symptoms that correspond to stored events
Plan: continue current settings, or document specific programming changes with rationale

For patients who received an ICD shock, document the event more extensively: the stored EGM if reviewed, the clinical circumstances, and whether the therapy was appropriate (treating true ventricular arrhythmia) or inappropriate (treating supraventricular arrhythmia, sensing artifact, or lead oversensing).

Cardiac Resynchronization Therapy (CRT) Optimization

For patients with cardiac resynchronization therapy (CRT), optimization visit notes should document:

AV delay and VV interval settings with the optimization method used (empiric, echocardiographic, device-based algorithm)
Percent biventricular pacing (target: >98%)
Any changes made to pacing settings and the rationale

Quality Reporting and ACC/AHA Metric Documentation

ACC NCDR and Quality Measure Fields

If your practice participates in ACC National Cardiovascular Data Registry (NCDR) programs, documentation needs to capture specific data fields for submission. Common examples:

For LVEF-based quality measures: document LVEF numerically and with the assessment method
For the ACC PINNACLE Registry (now NCDR Practice Innovation and Clinical Excellence): document NYHA class, GDMT medications with doses, blood pressure, and HF hospitalization history at every qualifying visit
For anticoagulation in AF: document CHA2DS2-VASc score components, anticoagulation prescribed (with specific agent and dose), and the reason if anticoagulation is not prescribed despite a score that meets guideline thresholds

Payer-Specific Requirements for HF Visits

Commercial payers and Medicare Advantage plans increasingly audit cardiology documentation for adherence to guideline-recommended care. Specific documentation gaps that trigger audits include:

Missing NYHA class at HF visits
No documentation of GDMT review or contraindication when guideline medications are absent
Absence of documented weight-based action plan for outpatient HF patients
No smoking cessation counseling note when tobacco use is listed as an active problem
Missing shared decision-making documentation for high-risk procedures (e.g., ICD implant in a patient with poor functional status or limited life expectancy)

The consistent documentation practice is straightforward: if you thought about it and acted on it clinically, it needs to be in the note.

Follow-Up Visit Efficiency Without Losing Clinical Detail

Cardiology follow-up visits are shorter than initial consultations, but the documentation requirement does not scale down proportionally. A HF follow-up note still needs to capture interval history, volume status assessment, GDMT review, labs, and plan.

A practical approach: build visit-type templates that capture the required fields without requiring a blank-page note each time. A HF follow-up template might prompt for: NYHA class today vs. last visit, weight change, edema grade, BP, current GDMT with any changes, renal function labs, and the plan. Filling in those fields from a template takes two to three minutes if the clinical reasoning has already been done during the visit.

For cardiologists managing high note volume, a documentation tool like NotuDocs lets you build your own cardiology-specific templates and fill them from post-visit notes, keeping the structure consistent without recording or transcribing sessions. It does not replace clinical judgment, but it removes the blank-page problem for recurring visit types.

Documentation Checklist for Cardiology Visits

Initial Consultation

Consult question documented explicitly if referral-based
HPI with symptom characterization specific to cardiovascular presentation
NYHA functional class documented
Cardiac history section separate from general PMH
Risk factors with specificity (HbA1c, pack-years, lipid values)
Cardiac exam components documented (JVP, heart sounds with grading, edema with grade)
EKG interpretation in provider's own language (not "EKG reviewed")
Imaging findings with quantitative data (LVEF by method, diastolic dysfunction grade, valve severity)

Heart Failure Management Visits

HF phenotype (HFrEF / HFmrEF / HFpEF) with current LVEF
ACC/AHA Stage and NYHA Functional Class at this visit
Volume status assessment: weight change, edema grade, JVP, lung exam
GDMT review: each of the four classes documented with dose, or explicit reason for absence
Loop diuretic dose with renal function and electrolytes if recently changed
Weight-based action plan confirmed or reviewed with patient

Device Management Visits

Device type, manufacturer, implant date
Battery longevity estimate
Lead parameters: sensing, pacing thresholds, impedances
Percent pacing since last interrogation
Arrhythmia log: any episodes, therapies, appropriate vs. inappropriate determination
Programming changes with rationale

Quality Reporting Fields

CHA2DS2-VASc score with individual components
LVEF documented numerically with method
Anticoagulation prescribed or contraindication documented
GDMT for HFrEF with doses or contraindications documented
Smoking status with counseling note if applicable